Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days

American Journal of Health-System Pharmacy

Volumn 53, Issue 12, 1996, Pages 1431-1435

  Hagan, Robert L ^a   Mallett, Mark S ^a   Fox, Janet L ^b  

^a DAVID GRANT MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ONDANSETRON;

CANCER CHEMOTHERAPY; DRUG STABILITY; HUMAN; INFUSION SYSTEM; NAUSEA; NOTE; PRIORITY JOURNAL; SYRINGE; VOMITING;

EID: 0029889704     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.12.1431     Document Type: Note

References (4)

1. Zofran injection package insert. Research Triangle Park, NC: Cerenex Pharmaceuticals; 1994 Apr.
2. AHFS drug information 94. McEvoy GD, ed. Bethesda, MD: American Society of Hospital Pharmacists; 1994.
3. Smith DB, Newlands ES, Rustin GJ et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin containing chemotherapy. Lancet. 1991; 338:487-90.
4. Bosso JA, Prince RA, Fox JL. Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25 °C Am J Hosp Pharm. 1992; 49:2223-5.